PRDM9 and chondrosarcoma: We previously showed that DZNep, an inhibitor of SAH known to reduce histone methyltransferase activity, induces apoptosis in vitro and in vivo in chondrosarcomas [3,4,5], without inducing deleterious effects on the majority of tissues, nor on cognitive functions in mice [16].